Patent · US Expired

Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia

US6362338B1 · kind B1 · utility

1Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 21, 2000
Grant dateMar 26, 2002
Priority date
Expiry dateJan 21, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to a series of substituted piperazines of Formula II, as well as enantiomers thereof These compounds are useful in the manufacture of pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.